Rhoads Ann D
- SEC CIK
- 0001250252
In the past year, 1 open-market purchase filing worth $21.2K and 1 sale filing worth $818.0K.
Current role at each company
- QDEL QuidelOrtho CorpDirectoras of Jun 29, 2026
- GMED Globus Medical IncDirectoras of Jun 8, 2026
- RPTX Repare Therapeutics Inc.Directoras of Jan 28, 2026
- ITOS iTeos Therapeutics, Inc.Directoras of Aug 29, 2025
- EVOK Evoke Pharma IncDirectoras of Jul 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $21.2K
- 1 filing
- Sold
- $818.0K
- 1 filing
- Net
- −$796.8K
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Rhoads Ann D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
QDEL QuidelOrtho Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 (view filing) | Dec 10 | Same day | Rhoads Ann DDirector | PPurchase | +750 | $28.28 | +$21.2K | +5.3%15.0K after |
GMED Globus Medical Inc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 10, 2025 (view filing) | Nov 7-10 | 3 days | Rhoads Ann DDirector | SSaleClass A Common Stock | −10.0K | $81.80 | −$818.0K | −39.4%15.4K after | 2 lots10b5-1 |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Rhoads Ann DDirector | SSaleClass A Common Stock | −10.0K | $58.46 | −$584.6K | −28.3%25.4K after | 10b5-1 |
| Mar 4, 2025 (view filing) | Feb 28 | 4 days | Rhoads Ann DDirector | SSaleClass A Common Stock | −7.50K | $78.68 | −$590.1K | −17.5%35.4K after | 10b5-1 |
| Sep 17, 2024 (view filing) | Sep 13 | 4 days | Rhoads Ann DDirector | SSaleClass A Common Stock | −15.0K | $70.36 | −$1.06M | −25.9%42.9K after |